1299 CONTEMPORARY INCIDENCE AND MORTALITY RATES OF RENAL CELL CARCINOMA IN THE UNITED STATES

2013 ◽  
Vol 189 (4S) ◽  
Author(s):  
Maxine Sun ◽  
Vincent QH Trinh ◽  
Florian Roghmann ◽  
Andreas Becker ◽  
Hugo Lavigueur-Blouin ◽  
...  
2019 ◽  
Vol 17 (1) ◽  
pp. 46-57.e5 ◽  
Author(s):  
Anas M. Saad ◽  
Mohamed M. Gad ◽  
Muneer J. Al-Husseini ◽  
Inas A. Ruhban ◽  
Mohamad Bassam Sonbol ◽  
...  

2019 ◽  
Vol 30 ◽  
pp. vi94
Author(s):  
Anas M. Saad ◽  
Mahmad Wafa Khoudeir ◽  
Muneer J. Al-Husseini ◽  
Inas A. Ruhban ◽  
Khalid A. Jazieh ◽  
...  

2011 ◽  
Vol 186 (5) ◽  
pp. 1779-1785 ◽  
Author(s):  
Simon P. Kim ◽  
Nilay D. Shah ◽  
Christopher J. Weight ◽  
R. Houston Thompson ◽  
James P. Moriarty ◽  
...  

2006 ◽  
Vol 4 (10) ◽  
pp. 1072 ◽  
Author(s):  
_ _

An estimated 38,890 Americans will be diagnosed with kidney cancer and 12,840 will die of this disease in the United States in 2006. Renal cell carcinoma (RCC) constitutes approximately 2% of all malignancies, with a median age at diagnosis of 65 years. Smoking and obesity are among the risk factors for RCC development, and tumor grade, local extent of the tumor, presence of regional nodal metastases, and evidence of metastatic disease at presentation are the most important prognostic determinants of 5-year survival. These guidelines discuss evaluation, staging, treatment, and management after treatment. For the most recent version of the guidelines, please visit NCCN.org


2011 ◽  
Vol 185 (4S) ◽  
Author(s):  
Sundeep Deorah ◽  
Rachna Raman ◽  
Krishnanath Gaitonde ◽  
Robert B. Bracken ◽  
James F. Donovan

Urology ◽  
2009 ◽  
Vol 74 (4) ◽  
pp. 837-841 ◽  
Author(s):  
Claudio Jeldres ◽  
Sara Baillargeon-Gagne ◽  
Daniel Liberman ◽  
Hendrik Isbarn ◽  
Umberto Capitanio ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document